Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 12, 2024Open Access

SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMatilde MurgaGLGema Lopez-PernasRSRobert Soliva

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Murga et al. (2024) studied this question.

synapsesocial.com/papers/68e651bbb6db6435875e1a3dhttps://doi.org/10.1101/2024.06.11.598464
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences2021 · 6,879 citations
  2. 2Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma2021 · 50 citations
  3. 3Epigenetic Determinants of Cancer2016 · 1,386 citations
  4. 4The histone methyltransferase Setd8 acts in concert with c‐Myc and is required to maintain skin2011 · 93 citations
  5. 5Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7‐deficient cells2022 · 30 citations